Full Text View
Tabular View
No Study Results Posted
Related Studies
Dose Safety, Tolerability, and Immunogenicity of a New Smallpox Vaccine in Adults Without Previous Smallpox Vaccination
This study has been terminated.
( CDC's decision to down-select vaccine development to single candidate, ACAM2000 )
Study NCT00053508   Information provided by Sanofi-Aventis
First Received: January 30, 2003   Last Updated: January 14, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Smallpox
More general conditions related to this trial
DNA Virus Infections
Poxviridae Infections
Virus Diseases
Interventions listed in this trial
ACAM1000
Sponsors listed in this trial
Sanofi-Aventis


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services